West Pharmaceutical Services, Inc. (NYSE:WST) Shares Bought by Hancock Whitney Corp

Hancock Whitney Corp increased its stake in West Pharmaceutical Services, Inc. (NYSE:WST) by 1.8% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 25,408 shares of the medical instruments supplier’s stock after purchasing an additional 451 shares during the period. Hancock Whitney Corp’s holdings in West Pharmaceutical Services were worth $8,369,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the stock. Vanguard Group Inc. boosted its stake in West Pharmaceutical Services by 1.2% in the 4th quarter. Vanguard Group Inc. now owns 9,002,632 shares of the medical instruments supplier’s stock worth $3,170,007,000 after purchasing an additional 104,740 shares in the last quarter. Artisan Partners Limited Partnership boosted its stake in West Pharmaceutical Services by 23.2% in the 4th quarter. Artisan Partners Limited Partnership now owns 1,961,063 shares of the medical instruments supplier’s stock worth $690,530,000 after purchasing an additional 369,792 shares in the last quarter. TD Asset Management Inc raised its position in West Pharmaceutical Services by 38.4% during the 4th quarter. TD Asset Management Inc now owns 659,560 shares of the medical instruments supplier’s stock worth $232,244,000 after buying an additional 183,153 shares during the last quarter. Findlay Park Partners LLP raised its position in West Pharmaceutical Services by 30.6% during the 1st quarter. Findlay Park Partners LLP now owns 597,106 shares of the medical instruments supplier’s stock worth $236,281,000 after buying an additional 139,800 shares during the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC raised its position in West Pharmaceutical Services by 6.8% during the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 593,692 shares of the medical instruments supplier’s stock worth $195,556,000 after buying an additional 37,702 shares during the last quarter. 93.90% of the stock is currently owned by institutional investors and hedge funds.

West Pharmaceutical Services Stock Performance

WST opened at $308.15 on Friday. West Pharmaceutical Services, Inc. has a 12-month low of $265.00 and a 12-month high of $413.70. The company has a current ratio of 2.34, a quick ratio of 1.68 and a debt-to-equity ratio of 0.03. The firm has a market capitalization of $22.45 billion, a PE ratio of 40.65, a P/E/G ratio of 10.58 and a beta of 1.01. The firm has a 50 day moving average of $303.37 and a two-hundred day moving average of $337.42.

West Pharmaceutical Services (NYSE:WST) last posted its quarterly earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.74 by ($0.22). West Pharmaceutical Services had a return on equity of 19.17% and a net margin of 18.25%. The business had revenue of $702.10 million for the quarter, compared to analysts’ expectations of $729.36 million. During the same period in the prior year, the business posted $2.11 earnings per share. The business’s quarterly revenue was down 6.9% compared to the same quarter last year. On average, analysts anticipate that West Pharmaceutical Services, Inc. will post 6.42 EPS for the current year.

Insiders Place Their Bets

In other West Pharmaceutical Services news, VP Charles Witherspoon sold 1,029 shares of the firm’s stock in a transaction that occurred on Monday, August 19th. The shares were sold at an average price of $300.00, for a total transaction of $308,700.00. Following the completion of the transaction, the vice president now directly owns 1,478 shares of the company’s stock, valued at approximately $443,400. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.53% of the stock is currently owned by insiders.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.